Sri Kaustubha Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth %
- Profit Growth -114.07%
- Ebitda -10.11%
- Net Worth -0.07%
- Total Assets -0.01%
About Sri Kaustubha Pharma
Sri Kaustubha Pharma Private Limited (SKPPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 May 2015 (Nine years and nine months 12 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mareddy Reddy, Madhavi Mareddy, Mareddy Ramakotireddy, and One other member serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100TG2015PTC098941
- Company No.
098941
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 May 2015
- Date of AGM
29 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Sri Kaustubha Pharma?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mareddy Tanmayee  | Director | 24-Nov-2017 | Current |
| Mareddy Reddy | Director | 15-May-2015 | Current |
| Madhavi Mareddy | Director | 15-May-2015 | Current |
| Mareddy Ramakotireddy | Director | 24-Nov-2017 | Current |
Financial Performance of Sri Kaustubha Pharma.
Sri Kaustubha Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 114.07% decrease in profit. The company's net worth dipped by a decrease of 0.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sri Kaustubha Pharma?
In 2017, Sri Kaustubha Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Emmes Bio Ventures Private LimitedMadhavi Mareddy and Mareddy Ramakotireddy are mutual person
- Sri Kaustubha Industries Private Limited
Madhavi Mareddy and Mareddy Ramakotireddy are mutual person
- Infoniant Systems Private Limited
Madhavi Mareddy, Mareddy Ramakotireddy and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sri Kaustubha Pharma?
Unlock and access historical data on people associated with Sri Kaustubha Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Kaustubha Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Kaustubha Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.